4/19/2024  9:59:57 PM Chg. +0.71 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
125.87USD +0.57% 192,405
Turnover: 24.18 mill.
-Bid Size: - -Ask Size: - 318.56 bill.USD 2.35% 898.43

Business description

Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through its prescription medicines, vaccines, biologic therapies and animal health products, the company works with customers and operate in more than 140 countries to deliver innovative health solutions. Merck also demonstrates its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
 

Management board & Supervisory board

CEO
Robert M. Davis
Management board
Caroline Litchfield, Sanat Chattopadhyay, Richard R. DeLuca, Jr., Cristal N. Downing, Chirfi Guindo, Michael A. Klobuchar, Steven C. Mizell, Jannie Oosthuizen, Joseph Romanelli, Dave Williams, Jennifer Zachary, Dean Y. Li, M.D., Ph.D.
Supervisory board
Robert M. Davis, Douglas M. Baker, Jr., Mary Ellen Coe, Pamela J. Craig, Thomas H. Glocer, Risa J. Lavizzo-Mourey, M.D., Stephen L. Mayo, Ph.D., Paul B. Rothman, M.D., Patricia F. Russo, Christine E. Seidman, M.D., Inge G. Thulin, Kathy J. Warden, Peter C. Wendell
 

Company data

Name: Merck & Co. Inc.
Address: 126 East Lincoln Avenue,Rahway, NJ 07065 USA
Phone: +1-908-740-4000
Fax: -
E-mail: -
Internet: www.merck.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 83.84%
IPO date: -

Investor relations

Name: -
IR phone: +1-732-594-1468
IR Fax: -
IR e-mail: investor_relations@merck.com

Company calendar

CW 17 | 4/25/2024 Interim Report 1st Quarter/3 Months
CW 22 | 5/28/2024 General Shareholder Meeting
CW 31 | 7/30/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 10/31/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Others
 
65.90%
Vanguard Group, Inc.
 
9.61%
Blackrock Inc.
 
8.24%
State Street Corporation
 
4.59%
Wellington Management Group, LLP
 
2.70%
Geode Capital Management, LLC
 
2.02%
Bank of America Corporation
 
1.58%
Morgan Stanley
 
1.54%
FMR, LLC
 
1.41%
Others
 
2.41%